What Happens During a Gastroenterologist Review for Fatty Liver Disease

What we cover in the first visit

We begin with a clear, focused review so you know the priorities. That usually includes:

• Medical history and symptoms, such as fatigue, abdominal discomfort or unexplained weight changes.
• Medication and supplement review, since common drugs and supplements can affect the liver.
• Alcohol and metabolic risk assessment, including diabetes, high cholesterol and obesity.
• Physical exam focused on signs of liver disease, like jaundice or enlarged liver.
• Baseline lab tests and a plan for imaging or noninvasive fibrosis testing.

We explain findings in plain language and how they affect decisions about further testing and follow up. If you have prior records or imaging, bring them or ask your primary care office to send them ahead of time so we can compare results.

Typical tests and what they tell us

Most reviews rely on a combination of blood tests, imaging and noninvasive fibrosis measures. Here are the common elements and why we use them.

Blood tests

We review liver function tests such as alanine aminotransferase and aspartate aminotransferase, a complete metabolic panel, platelet count and tests for other causes of liver injury. These give an initial sense of liver inflammation and synthetic function.

Imaging

Abdominal ultrasound is the most common first imaging test to look for steatosis, or fat in the liver. Ultrasound is widely available and helps rule out obvious structural problems.

Noninvasive fibrosis assessment

When we need to estimate scarring, we use tools such as transient elastography, commonly called FibroScan, or blood based fibrosis scores. These tests help decide whether biopsy or referral to a liver specialist is necessary.

When biopsy or advanced imaging is needed

A liver biopsy is rarely the first step. We consider it when noninvasive tests give unclear results, when autoimmune or metabolic liver disease is suspected, or when treatment decisions require exact fibrosis staging.

For background on fatty liver and how it develops, we refer to authoritative guidance from the National Institute of Diabetes and Digestive and Kidney Diseases which summarizes current prevalence and definitions for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. See their overview for more details: https://www.niddk.nih.gov/health-information/liver-disease/nafld-nash

A typical timeline for review and follow up

1. Initial history and exam. We collect symptoms, medications and risk factors and perform a focused exam.
2. Baseline labs ordered or reviewed. Results usually return in 2 to 7 days, depending on the lab.
3. Imaging scheduled or reviewed. Ultrasound appointments often fall within 1 to 2 weeks; elastography scheduling varies by clinic.
4. Results discussion and risk stratification. We explain whether findings suggest simple steatosis or concern for fibrosis.
5. Care plan and referrals. For patients with advanced fibrosis or unclear diagnosis we coordinate referral to a hepatologist or order further testing.
6. Ongoing monitoring. For most patients with mild disease we set a monitoring schedule with periodic labs and imaging.

Timing varies by local availability and by whether we are reviewing tests sent from another provider. If you are a patient of Dr. Alan R. Plumer, MD, we will coordinate records and testing so you do not repeat work unnecessarily.

How we interpret common results

Interpreting liver tests and images is partly pattern recognition and partly context. Two important concepts we use are steatosis and fibrosis.

Steatosis versus fibrosis

Steatosis means fat in the liver and may be reversible with lifestyle changes and control of metabolic factors. Fibrosis means scarring. Fibrosis stage predicts long term risk, so our decision making focuses on estimating fibrosis accurately.

What elevated enzymes mean

Moderate elevations of ALT or AST often reflect inflammation from fatty liver, but we also screen for viral hepatitis, autoimmune liver disease and medication effects. Normal enzymes do not rule out fibrosis, so we combine labs with elastography or scores when indicated.

When we refer to a hepatologist

We refer if noninvasive testing suggests significant fibrosis, if multiple causes of liver disease are possible, or if you would benefit from specialist management for cirrhosis or complications. We provide a shared care plan when we refer so you have clear next steps.

Treatment approaches we discuss

Our role is to present safe, evidence based options and to coordinate care. For fatty liver disease this usually includes:

• Targeted lifestyle measures focused on sustainable weight loss, nutrition and exercise.
• Management of coexisting conditions such as type 2 diabetes and high cholesterol.
• Medication review to stop or change drugs that can harm the liver when possible.
• Discussion of medications under study for NASH when appropriate, and when referral to a hepatology center may be helpful.

We do not prescribe experimental therapies outside approved indications, and we explain the tradeoffs and evidence behind each option. When medication decisions cross into specialty territory we coordinate with our hepatology colleagues.

How you can prepare for the visit

Red flags and when to seek urgent care

Most fatty liver disease reviews are outpatient and not urgent. However, certain signs require prompt evaluation.

We make sure you understand which symptoms require rapid evaluation and which can be handled through routine follow up.

Common questions we hear

Below are answers to frequent concerns patients bring to a fatty liver review.

• Can fatty liver be reversed? In many cases, early fatty liver due to metabolic causes can improve with sustained weight loss and control of diabetes and lipids. Those are the primary interventions we emphasize.
• Will I need a biopsy? Most patients do not need a liver biopsy. We reserve biopsy for cases where noninvasive tests are inconclusive or when tissue will change management.
• How often will I be followed? Follow up depends on fibrosis risk. Patients with minimal disease often return for labs and imaging every 12 months, while higher risk patients are seen more frequently.
• Can medications cause fatty liver? Some medications and supplements can cause or worsen liver injury. Part of our review is identifying those and adjusting therapy when safe.